D. Rovini

发表

High prevalence of the G101W germline mutation in the CDKN2A (P16(ink4a)) gene in 62 Italian malignant melanoma families.

A. Goldstein, P. Queirolo, B. Pasini, 2002, American journal of medical genetics.

Cell kinetics as a prognostic marker in locally advanced breast cancer.

G. Bonadonna, M. Daidone, R. Silvestrini, 1987, Cancer treatment reports.

Immunodetection of bone marrow micrometastases in breast carcinoma patients and its correlation with primary tumour prognostic features.

A. Luini, S. Ménard, U. Veronesi, 1994, British Journal of Cancer.

Microcalcifications in clinically normal breast: the value of high field, surface coil, Gd-DTPA-enhanced MRI

L. Balzarini, E. Civelli, D. Rovini, 1995, European Radiology.

CDKN2A and CDK4 mutation analysis in Italian melanoma-prone families: functional characterization of a novel CDKN2A germ line mutation

G. Peters, M. Pierotti, B. Pasini, 2001, British Journal of Cancer.

Surgical treatment of phyllodes tumors of the breast

S. Andreola, B. Salvadori, D. Rovini, 1989, Cancer.

Risk of invasive cancer in women with lobular carcinoma in situ of the breast.

C. Bartoli, B. Salvadori, S. Zurrida, 1991, European journal of cancer.

Surgery for local recurrences following deficient radical mastectomy for breast cancer: a selected series of 39 cases.

B. Salvadori, D. Rovini, P. Squicciarini, 1992, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Immunoglobulin Allotypes in Familial Malignant Melanoma

M. Martinetti, C. Lombardo, L. Salvaneschi, 1989, Tumori.

HLA Antigens in Familial and Sporadic Cutaneous Melanoma

N. Cascinelli, M. Santinami, D. Rovini, 1988, Tumori.

Hla Antigens in Malignant Melanoma Patients

D. Rovini, M. Vaglini, N. Cascinelli, 1980, Tumori.

HRAS1 proto-oncogene polymorphisms in human malignant melanoma: TaqI defined alleles significantly associated with the disease.

M. Borrello, P. Radice, M. Pierotti, 1987, Oncogene.

Prognosis of stage I melanoma of the skin. Who collaborating centres for evaluation of methods of diagnosis and treatment of melanoma

Institut Gustave Roussy, M. Dabska, D. Rovini, 1980, International journal of cancer.

Lower Frequency of Sister Chromatid Exchanges and Altered Frequency of HLA B-region Alleles among Individuals with Sporadic Dysplastic Nevi

D. Rovini, N. Cascinelli, M. T. Illeni, 1997, The International journal of biological markers.

Multimodal treatment for locally advanced breast cancer. Result of chemotherapy-radiotherapy versus chemotherapy-surgery.

G. Bonadonna, U. Veronesi, R. Zucali, 1981, Cancer clinical trials.

HLA complex and familial malignant melanoma

N. Cascinelli, D. Rovini, M. Vaglini, 1982, International journal of cancer.

S100 protein serum levels in cutaneous malignant melanoma.

N. Cascinelli, M. Greco, E. Seregni, 1998, Oncology reports.

Management of nodal metastases from head and neck melanoma

M. Santinami, D. Rovini, F. Belli, 1989, Journal of surgical oncology.

Sister chromatid exchange and proliferation pattern in stimulated lymphocytes of cutaneous malignant melanoma patients.

D. Rovini, E. Raimondi, E. Privitera, 1985, Cancer genetics and cytogenetics.

HLA antigens in ovarian adenocarcinoma patients.

S. Böhm, D. Rovini, M. Pasquali, 1985, European journal of gynaecological oncology.

Inconsistent expression of HLA-B antigens on peripheral blood lymphocytes of stage I melanoma patients: an indicator of poor prognosis.

N. Cascinelli, D. Rovini, R. Bufalino, 1994, European journal of cancer.

Prognosis of skin melanoma with regional node metastases (stage II)

N. Cascinelli, A. Morabito, M. Santinami, 1984, Journal of surgical oncology.

Seven years experience with hyperthermic perfusions in extracorporeal circulation for melanoma of the extremities

N. Cascinelli, M. Santinami, D. Rovini, 1989, Journal of surgical oncology.

Regional Perfusion at High Temperature in Treatment of Stage IIIA-IIIAB Melanoma Patients

N. Cascinelli, M. Ammatuna, M. Santinami, 1983, Tumori.

Ten year results of a randomised trial comparing two conservative treatment strategies for small size breast cancer.

L. Mariani, U. Veronesi, R. Zucali, 1998, European journal of cancer.

T3b-T4 breast cancer: factors affecting results in combined modality treatments

G. Bonadonna, R. Zucali, P. Valagussa, 1983, Clinical & Experimental Metastasis.

Use of monoclonal antibody MBr1 to detect micrometastases in bone marrow specimens of breast cancer patients.

S. Ménard, F. Rilke, S. Andreola, 1990, European journal of cancer.

Treatment for Paget's disease of the breast without an underlying mass lesion: an unresolved problem

C. Bartoli, B. Salvadori, S. Zurrida, 1993 .

Sister chromatid exchange in phytohemagglutinin-stimulated lymphocytes of nonfamilial cutaneous malignant melanoma patients.

D. Rovini, E. Raimondi, E. Privitera, 1984, Basic life sciences.

Sister chromatid exchange analysis in familial groups of malignant melanoma patients.

D. Rovini, M. Placucci, C. Grassi, 1991, Cancer Genetics and Cytogenetics.

Malignant melanoma: sister chromatid exchange analysis in three families.

D. Rovini, E. Raimondi, E. Privitera, 1983, Cancer genetics and cytogenetics.

Thermal Gradient and Response to Estrogens or Antiestrogens in Advanced Breast Cancer

A. Luini, G. Muscolino, D. Rovini, 1980, Tumori.